Literature DB >> 731021

Haemagglutination-inhibition test for the detection of rubella antibody.

.   

Abstract

Between 1969 and 1972 three quality control studies were set up to investigate the variation in results that was occurring between and within laboratories performing routine tests for the diagnosis of rubella infection. No attempt was made to standardize the test in these studies, and a wide range in titres of sera was reported. The aims of the present studies were:(i) to investigate in greater detail whether results were more reproducible between laboratories if test sera were compared with control sera of known potency and the results given in international units of activity, and(ii) to ascertain whether results between laboratories would be more reproducible if a standard test procedure was used.Eleven laboratories participated in testing 38 sera on three separate occasions by a prescribed standard technique and by that used routinely in each laboratory. Eight of the 38 sera consisted of four pairs of duplicate samples.Analysis of results of the study showed that the reproducibility between laboratories was substantially improved when the test sera were compared with a control serum of known potency and when a standard test procedure was used.Variation in results between laboratories was least when a control serum of low rather than high potency was used. Variation within laboratories can be reduced by increasing the number of times the control and test sera are tested.Since the rubella antibody content of the British Standard anti-rubella serum is expressed in international units, the potency of the control and results of test sera should also be expressed in such units.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731021      PMCID: PMC2130055     

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  4 in total

1.  The British Standard for anti-rubella serum.

Authors:  M Clarke; J A Dudgeon; R Ferris; G Colinet; H Tate; F T Perkins
Journal:  J Biol Stand       Date:  1975

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure.

Authors:  G Haukenes; H Blom
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

4.  Identification of non-specific serum inhibitors of rubella virus haemagglutination.

Authors:  H Blom; G Haukenes
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

  4 in total
  4 in total

1.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

2.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

3.  Rubella antibodies in Australian immunoglobulin products.

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 4.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.